23 participants
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-29
- Start Date:
- 2020-12-04
- Completion:
- 2027-12-31
Conditions
- Recurrent Follicular Lymphoma
- Refractory Follicular Lymphoma
Interventions
- DRUG
No Results Yet